JAN 11, 2021 10:50 AM PST

Sentinel Nodes Could Reveal a Tumor's Prognosis

WRITTEN BY: Jasper Cantrell

For many diseases, the ability to quickly and effectively diagnose or prognose a patient is critical. If caught early on, doctors and patients are given the time to properly analyze and treat the disease, which often results in a far better outlook for the patient.

This is doubly true in cancer. If caught early, many cancers can be treated quite easily with surgery and follow-up chemotherapy or radiotherapy. A smaller and more localized cancer is usually easier to get rid of. Once a tumor progresses to metastasis, it becomes incredibly difficult to treat effectively.

Diagnostic and prognostic tests sensitive enough to catch cancer early are a huge area of interest for researchers. Many studies have put forward candidate indicators that might be able to track the prognosis of certain cancers. In a new study out of the Karolinska Institute in Sweden, a team of scientists sought to use T-cell populations in sentinel lymph nodes as a prognostic indicator for oral squamous cell carcinomas.

A sentinel lymph node is the lymph node cancer would have most likely reached first. Lymph nodes are critical organs of the immune system and are essentially responsible for filtering and identifying problematic things in your blood (cancer being one such example). It stands to reason that the T-cell (a type of immune cell) population of a sentinel node would be different than in another lymph node, as the immune system reacts to the cancerous cell’s being caught in the sentinel node.

To test their hypothesis, the team enrolled 28 oral squamous cell carcinoma patients into this new study. They would obtain samples of the tumor, the sentinel node, and a non-sentinel lymph node to measure their respective T-cell populations. The team found that when a patient had a low CD69 and C4 Positive T-cell population, there was a significant decrease in disease-free survival. This was also the case when the sentinel nodes had an increase in CD8 and CD HLA-DR, positive T-cell populations.

These results suggest that sentinel lymph nodes are affected by cancers. This results in a change in the T-cell population compared to non-sentinel lymph nodes. While this could very well be used as a prognostic indicator for oral squamous cell carcinoma patients, the team also notes it could reveal an altering of the immune system at the lymph nodes. Cancer is already known to alter the immune environment surrounding a tumor. If it could also affect the immune system at other locations before metastasis, identifying these locations might assist future therapies.

The study concludes, “We demonstrate that the use of flow cytometry to characterize activation of T-cells in sentinel node may serve as an important prognostic marker, which could improve patients’ surveillance strategy and overall survival.”

Sources: Nature Scientific Reports, University of Minnesota Health

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
DEC 14, 2020
Cancer
Fibronectin Could Act as a Biomarker for Early Prognosis of Live Cancer
DEC 14, 2020
Fibronectin Could Act as a Biomarker for Early Prognosis of Live Cancer
Diagnostics is one of the key pillars of modern medicine. Diagnostics allows patients and doctors to identify a problem ...
DEC 21, 2020
Cancer
Cancer survivors have a higher risk of developing subsequent primary cancers
DEC 21, 2020
Cancer survivors have a higher risk of developing subsequent primary cancers
New research published in JAMA has found that cancer survivors have a higher risk of developing subsequent primary cance ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
JAN 06, 2021
Immunology
What's Causing Prostate Cancer Patients to Doze Off?
JAN 06, 2021
What's Causing Prostate Cancer Patients to Doze Off?
For prostate cancer patients, androgen deprivation therapy or ADT is a standard treatment aimed at stalling the growth o ...
JAN 17, 2021
Cancer
Analyzing the role of our circadian clocks in prostate cancer
JAN 17, 2021
Analyzing the role of our circadian clocks in prostate cancer
Research published recently in Nature Communications looks into the role that circadian rhythms play on prostate cancer ...
Loading Comments...